Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Nephrology · Hereditary Hypophosphatemic Rickets with Hypercalciuria

Lab Tests & Reports: Decoding the Diagnostic Puzzle

At a Glance

HHRH is suggested by low blood phosphate, high or high-normal active vitamin D, high urine calcium, low or low-normal PTH, and appropriately low FGF23. TRP and TmP/GFR assess kidney phosphate wasting, while genetic testing helps distinguish HHRH or NPHLOP1 from XLH.

Navigating lab reports for Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) or NPHLOP1 can feel like piecing together a complex puzzle. Because these conditions are rare, a single abnormal value is rarely enough for a diagnosis. Instead, specialists look for a “biochemical pattern” of blood and urine results that shows how your kidneys and hormones are reacting to a phosphate “leak” [1][2].

The Diagnostic Pattern: Your Biochemical Fingerprint

When reviewing your reports, look for this specific combination of findings, which is characteristic of FGF23-independent phosphate wasting [1][3]:

  • Serum Phosphate (Low): This is the starting point. Your blood phosphate levels will be below the normal range for your age (hypophosphatemia) [4].
  • 1,25-Dihydroxyvitamin D (High or High-Normal): This is the “active” form of vitamin D (also called calcitriol). In HHRH, your body appropriately increases this hormone to try to pull more phosphate from your diet [5].
  • Urine Calcium (High): Known as hypercalciuria, this is a characteristic finding in HHRH. High active vitamin D leads to increased calcium absorption in the gut, which the kidneys then excrete into the urine [6].
  • PTH (Low or Low-Normal): Unlike many other bone diseases, parathyroid hormone (PTH) is often suppressed or at the lower end of the normal range because your body is trying to manage calcium levels [3][7].
  • FGF23 (Appropriately Low): In HHRH, this hormone should be appropriately low in response to your low phosphate. If it is high, it points toward a different condition like XLH [8][1].

Proving the “Leak”: TRP and TmP/GFR

Finding low phosphate in your blood is not enough; your doctor must confirm that your kidneys are inappropriately excreting it. They calculate this by measuring paired blood and urine samples [9].

  • TRP (Tubular Reabsorption of Phosphate): This calculates the percentage of phosphate your kidneys recapture. Rather than relying on a rigid cutoff (like 95%), specialists look for an inappropriately low TRP given your low blood phosphate [10][9].
  • TmP/GFR: This is a more precise calculation that accounts for your kidney’s filtration rate. It must be interpreted against age-appropriate reference ranges. Ensure you follow your specific laboratory’s instructions for fasting and urine collection to get an accurate result [11][10].

The Role of Genetic Testing

While blood and urine tests suggest the diagnosis, genetic testing provides molecular confirmation and guides family counseling.

  • SLC34A3: Testing this gene confirms classic HHRH. Finding two mutations (biallelic) usually means classic rickets and stones, while one mutation (monoallelic) may explain isolated kidney stones or hypercalciuria [2][6].
  • SLC34A1: Testing this gene can identify NPHLOP1, which involves a different phosphate transporter but shares a similar phenotype [12].
  • Important Caveat: A positive test provides molecular confirmation, but a negative gene panel or a “Variant of Uncertain Significance” (VUS) does not completely rule out the clinical disorder. Diagnosis requires interpreting the genetics alongside your clinical symptoms, family history, and lab results [2].

Differentiating HHRH from XLH

It is critical to distinguish HHRH from X-Linked Hypophosphatemia (XLH) because the treatments are fundamentally different. The key markers that set HHRH apart from XLH are inappropriately high active vitamin D and high urine calcium. In XLH, active vitamin D is usually low or inappropriately normal and urine calcium is normal or low [7][13]. Identifying these differences ensures you receive appropriate therapy without the dangerous addition of active vitamin D supplements [14].

Understanding Vitamin D Labs

Test Name What It Is Expected in Untreated HHRH Notes
25-Hydroxyvitamin D Nutritional Vitamin D (Stores) Normal or Low Depends on diet/sun. Deficiency may still need careful treatment.
1,25-Dihydroxyvitamin D Active Vitamin D (Calcitriol) High or High-Normal The body naturally overproduces this in response to low phosphate.

Simplified Untreated Diagnostic Patterns:

Lab Marker HHRH / NPHLOP1 XLH / FGF23-Mediated
Active Vit D (1,25) High or Inappropriately Normal [5] Low/Normal [13]
Urine Calcium High [6] Low/Normal [7]
PTH Low/Normal [3] Normal/High [2]
FGF23 Appropriately Low [1] Inappropriately High [7]
Alk Phos High (if rickets) [15] High [2]

Common questions in this guide

What blood and urine pattern is typical of HHRH?
HHRH usually produces low blood phosphate, high or high-normal active vitamin D, high urine calcium, low or low-normal PTH, and appropriately low FGF23. Clinicians interpret these results together because one abnormal value alone does not establish the diagnosis.
How do TRP and TmP/GFR show that my kidneys are wasting phosphate?
TRP estimates the percentage of filtered phosphate that the kidneys reclaim, while TmP/GFR estimates the kidney’s phosphate reabsorption capacity. An inappropriately low result for a person with low blood phosphate supports renal phosphate wasting, but age, kidney function, and paired sample collection affect interpretation.
How do HHRH lab results differ from XLH?
HHRH typically has high or inappropriately normal active vitamin D, high urine calcium, and appropriately low FGF23. XLH usually has low or inappropriately normal active vitamin D, normal or low urine calcium, and inappropriately high FGF23; the distinction matters because treatments differ.
Which genetic tests are used for HHRH and NPHLOP1?
SLC34A3 testing can confirm classic HHRH, especially when two disease-causing variants are found. SLC34A1 testing can identify NPHLOP1, a related phosphate-wasting disorder with a similar clinical pattern.
Can a negative genetic panel rule out HHRH or NPHLOP1?
No. A negative panel or a variant of uncertain significance does not completely exclude HHRH or NPHLOP1, so clinicians interpret genetic results with symptoms, family history, and blood and urine findings.
Can supplements or collection methods change my phosphate and calcium results?
Yes. Phosphate, calcium, and vitamin D supplements may affect results, and fasting or urine collection errors can make paired testing less reliable. Tell your care team what you take and follow the performing laboratory’s instructions.
Why might my doctor order a kidney ultrasound or CT scan?
Imaging can look for calcium deposits called nephrocalcinosis or for kidney stones associated with high urine calcium. It complements blood, urine, and genetic testing but does not by itself diagnose HHRH or NPHLOP1.

Get notified when new evidence is published on nephrolithiasis/osteoporosis, hypophosphatemic.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    Genu Valgum, Fractures, and Renal Stones in a 10-year-old Girl.

    Christensen S, Loomba LA

    JCEM case reports 2023; (1(1)):luac022 doi:10.1210/jcemcr/luac022.

    PMID: 37908277
  2. 2

    Clinical and Molecular Genetic Characteristics of Patients with Hereditary Hypophosphatemia.

    Eltan M, Alavanda C, Yavas Abali Z, et al.

    The Journal of clinical endocrinology and metabolism 2025; (110(9)):e3021-e3030 doi:10.1210/clinem/dgae868.

    PMID: 39700445
  3. 3

    Phosphate matters when investigating hypercalcemia: a mutation in SLC34A3 causing HHRH

    Tang AR, Hinz LE, Khan A, Kline GA

    Endocrinology, diabetes & metabolism case reports 2019; (2019(1)):1-6 doi:10.1530/EDM-19-0058.

    PMID: 31352694
  4. 4

    Growth hormone therapy in HHRH.

    Filler G, Schott C, Salerno FR, et al.

    Bone reports 2022; (16()):101591 doi:10.1016/j.bonr.2022.101591.

    PMID: 35663378
  5. 5

    Late diagnosis of SLC34A3-related hereditary hypophosphatemic osteomalacia following a low-energy proximal humeral 4-part fracture.

    Morimoto T

    JBMR plus 2026; (10(10)):ziag137 doi:10.1093/jbmrpl/ziag137.

    PMID: 42741772
  6. 6

    An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH).

    Zhu Z, Bo-Ran Ho B, Chen A, et al.

    Kidney international 2024; (105(5)):1058-1076 doi:10.1016/j.kint.2024.01.031.

    PMID: 38364990
  7. 7

    Two variants in SLC34A3 in a patient with X-linked hypophosphatemia: a diagnostic and therapeutic dilemma.

    Sharova M, Klimova E, Filatova A, et al.

    Pediatric nephrology (Berlin, Germany) 2026; doi:10.1007/s00467-026-07520-2.

    PMID: 42684400
  8. 8

    Clinical Spectrum of Hereditary Hypophosphatemic Rickets With Hypercalciuria (HHRH).

    Stürznickel J, Heider F, Delsmann A, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(8)):1580-1591 doi:10.1002/jbmr.4630.

    PMID: 35689455
  9. 9

    Reflections on TRP and TP/GFR in the definition of renal phosphate loss: conceptual review.

    García-Nieto VM, González-Rodríguez JD, Cabrera-Sevilla JE, et al.

    Pediatric nephrology (Berlin, Germany) 2023; (38(11)):3845-3848 doi:10.1007/s00467-023-05941-x.

    PMID: 37052691
  10. 10

    Hypophosphatemia in acute liver failure of a broad range of etiologies is associated with phosphaturia without kidney damage or phosphatonin elevation.

    Zechner C, Adams-Huet B, Gregory B, et al.

    Translational research : the journal of laboratory and clinical medicine 2021; (238()):1-11 doi:10.1016/j.trsl.2021.07.003.

    PMID: 34298149
  11. 11

    Tubular phosphate transport: a comparison between different methods of urine sample collection in FGF23-dependent hypophosphatemic syndromes.

    Arcidiacono GP, Camozzi V, Zaninotto M, et al.

    Clinical chemistry and laboratory medicine 2024; (62(6)):1126-1132 doi:10.1515/cclm-2023-1292.

    PMID: 38295343
  12. 12

    Digenic Heterozygous Mutations in SLC34A3 and SLC34A1 Cause Dominant Hypophosphatemic Rickets with Hypercalciuria.

    Gordon RJ, Li D, Doyle D, et al.

    The Journal of clinical endocrinology and metabolism 2020; (105(7)) doi:10.1210/clinem/dgaa217.

    PMID: 32311027
  13. 13

    FGF23-Mediated Hypophosphatemic Rickets: Phenotype, Genotype, and Comparison to Non-FGF23-Mediated Forms.

    Karlekar MP, Dodamani MH, Lila A, et al.

    Indian pediatrics 2025; (62(3)):211-216 doi:10.1007/s13312-025-00024-6.

    PMID: 40126839
  14. 14

    Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy.

    Bergwitz C, Miyamoto KI

    Pflugers Archiv : European journal of physiology 2019; (471(1)):149-163 doi:10.1007/s00424-018-2184-2.

    PMID: 30109410
  15. 15

    SLC34A3 GENE MUTATION AS A RARE CAUSE OF HYPOPHOSPHATEMIA IN TWO SIBLINGS.

    Karakilic-Ozturan E, Ozturk AP, Oney C, et al.

    Acta endocrinologica (Bucharest, Romania : 2005) 2022; (18(3)):387-391 doi:10.4183/aeb.2022.387.

    PMID: 36699160

This page is for informational purposes only and does not constitute medical advice. It explains HHRH and NPHLOP1 test patterns, but your nephrologist, endocrinologist, or genetic counselor must interpret your results.